Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Accurate diagnosis of RDEB-mitis in older adults is crucial for proper management without immunosuppressants.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Tofacitinib may help regrow hair in alopecia areata patients.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Epiregulin can help hair grow and may be useful for treating hair loss.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

ERULUS is crucial for root hair growth by controlling calcium levels.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib is effective and safe for treating alopecia areata.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.